Moleculin Biotech, Inc. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
Moleculin Biotech, Inc. (MBRX) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $750.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-24.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2021-03-24
- Moleculin Biotech, Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2020 was $750.00K.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 1 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|
| 2020-12-31 | $750.00K 10-K · filed 2021-03-24 | ||
| 2016-05-31 | $750.00K 10-Q · filed 2017-08-11 | ||
| 2016-05-02 | $750.00K 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |